Organoids are miniaturized three-dimensional (3D) structures that mimic the characteristics of tissues. To study organoids’ development, cellular heterogeneity, and drug response, it is necessary to ...

Tumor heterogeneity drives chemotherapy resistance in cancer, necessitating the development of strategies to target diverse cellular subpopulations. Single-cell-derived tumor organoids (STOs), derived ...

Neurological diseases, including Parkinson’s and Alzheimer’s, continue to be a significant global health challenge. Progress has been hindered by a number of bottlenecks, despite considerable ...